China's National Medical Products Administration has approved a record 138 new drugs for pediatric use in 2025, marking the fifth consecutive year of growth in this sector. This surge in approvals is attributed to supportive government policies aimed at resolving long-standing issues with the availability and suitability of children's medications. Over the past five years, a total of 449 pediatric drugs have been approved in China, significantly improving the landscape for child healthcare. AI
RANK_REASON The cluster reports a record number of drug approvals for a specific demographic, indicating a significant trend and policy impact. [lever_c_demoted from significant: ic=1 ai=0.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →